5/10
08:39 am
rxrx
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
Medium
Report
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
5/10
05:29 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
5/10
05:29 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
4/9
08:09 am
rxrx
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
Low
Report
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
4/9
06:18 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
4/9
06:18 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX